ArticleJournal of cancer research and clinical oncology2024
Sintilimab plus GemOx is an effective salvage therapy in patients with refractory/relapsing nodal peripheral T cell lymphomas.
Xibin Xiao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.